Dublin, Dec. 07, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/qxcw2g/animal) has announced the addition of Jain PharmaBiotech's new report "Animal Biotechnology - Technologies, Markets and Companies" to their offering.
Approximately 120 companies have been identified to be involved in animal biotechnology and are profiled in the report. These are a mix of animal healthcare companies and biotechnology companies. Top companies in this area are identified and ranked. Information is given about the research activities of 11 veterinary and livestock research institutes. Important 108 collaborations in this area are shown.
The report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important in the application of biotechnology to manage genetic disorders and improve animal breeding. Genomics, proteomics and bioinformatics are also being applied to animal biotechnology.
Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans.RNA interference technology is now being applied for research in veterinary medicine
Molecular diagnosis is assuming an important place in veterinary practice. Polymerase chain reaction and its modifications are considered to be important. Fluorescent in situ hybridization and enzyme-linked immunosorbent assays are also widely used. Newer biochip-based technologies and biosensors are also finding their way in veterinary diagnostics.
Biotechnology products are approved by the Center for Veterinary Medicine of the FDA. Regulatory issues relevant to animal biotechnology are described.
The text is supplemented with 35 tables and 5 figures. Selected 260 references from the literature are appended.
Key Topics Covered:
Executive Summary
1. Introduction to Animal Biotechnology
2. Application of Biotechnology in Animals
3. A Biotechnology Perspective of Animals Diseases
4. Molecular Diagnostics in Animals
5. Biotechnology-based Veterinary Medicine
6. Research in Animal Biotechnology
7. Animal Biotechnology Markets
8. Regulatory issues
9. Companies Involved in Animal Biotechnology
10. References
For more information visit http://www.researchandmarkets.com/research/qxcw2g/animal
Source: Jain PharmaBiotech
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology


Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target 



